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Abstract
Background: Staphylococcus aureus immunodominant surface antigen B (IsaB) elicits an immune
response during septicemia and is generally classified as a virulence factor, but its biological function
remains completely undefined. In an attempt to identify staphylococcal RNA-binding proteins, we
designed an RNA Affinity Chromatography assay and subsequently isolated IsaB.
Results: Western analysis indicated that IsaB was both secreted and cell-surface associated. Gel
Shift analysis confirmed the RNA binding activity but revealed that IsaB bound to any nucleic acid
without sequence specificity. IsaB exhibited the highest affinity for double-stranded DNA followed
by single-stranded DNA and RNA. Because extracellular DNA has been shown to play a role in
biofilm formation, we investigated the biofilm-forming capacity of an isogenic isaB deletion mutant
but we found that IsaB did not contribute to biofilm formation under any conditions tested.
Conclusion: IsaB is an extracellular nucleic acid binding protein, with little to no sequence
specificity, but its role in virulence remains unclear.

Background
S. aureus is one of the leading causes of nosocomial infections and is re-emerging as a major threat among hospitals due to the spread of methicillin resistant strains
(MRSA)[1]. Furthermore, the occurrence of community
acquired MRSA (CA-MRSA) is on the rise in this country
and many others [2]. S. aureus has a multitude of virulence
factors that allow for host immune evasion, adherence to
host tissues, biofilm formation, toxin production, and
dissemination during infection [3]. As the biological functions of cellular components continue to be elucidated,
[4] more and more virulence factors are added to this
extensive list. In a study designed to elucidate potential
vaccine targets in S. aureus, Lorenz et al identified a pro-

tein, which they designated the immunodominant surface
antigen B (IsaB), that elicited an immune response during
MRSA septicemia. IsaB is a 19.5 kDa S. aureus protein with
no significant homology to other proteins with known
function [5]. Another study demonstrated a mutation in
the gene encoding IsaB in a hyper-virulent musculoskeletal isolate, leading the authors to suggest that mutation or
loss of IsaB may increase immune evasion in the S. aureus
isolate under investigation [6]. Other labs have reported
microarray data showing that isaB expression is increased
in response to neutrophil exposure, in biofilms, under
anaerobic conditions, and following internalization into
human epithelial cells [4,7-9]. All of these phenomena
suggest that in spite of its role in eliciting an immune
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response, IsaB expression is induced during infection.
Currently, IsaB is annotated as a putative virulence factor,
however its function has yet to be determined.
Biofilms have been shown to be a critical component of
certain S. aureus infections, as these structures confer
increased survival of the bacteria under many stressful
conditions such as low nutrient availability, antibiotic
challenge, oxidative stress, and host immune defenses
[10]. The major intercellular adhesin in S. aureus biofilms
is the polysaccharide poly-N-acetylglucosamine (PNAG),
which is encoded by the intercellular adhesin locus (ica)
[11,12]. We and others have previously studied the regulation of PNAG production and ica expression at the transcriptional level [13-17]. With the aim of characterizing
post-transcriptional regulation of ica expression, we
designed an RNA Affinity Chromatography assay to isolate proteins with high affinity for the 5'-untranslated
region of the ica transcript. We isolated a single protein,
IsaB. Subsequently, we found that IsaB did not play a role
in regulation of ica expression, was not localized to the
cytoplasm where it could potentially play a regulatory role
but rather was secreted and partially associated with the
bacterial cell surface, and bound to RNA, ssDNA, and
dsDNA with no apparent sequence specificity. Because a
number of studies have shown a role for extracellular
DNA in biofilm formation, we hypothesized that the
extracellular DNA-binding protein IsaB could play a role
in this process [18-21]. However, we found that IsaB did
not contribute to biofilm formation under a variety of
conditions. This study is the first to assign a function to
the putative virulence factor IsaB. The physiologic role of
binding extracellular nucleic acids is still unclear.

Results
Isolation of IsaB by RNA Affinity Chromatography
We hypothesized that an RNA-binding protein could regulate ica expression at the post-transcriptional level
through binding to the 5'-untranslated region (5'-UTR).
To isolate factors that bound to the 5'-UTR, we designed
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an RNA Affinity Chromatography assay using a biotinylated chimeric oligonucleotide (WTUTR-c) based on
the sequence upstream from the ica locus as shown in
Table 1. The 3-nt at the beginning and end were synthesized as deoxyribonucleotides to protect the oligo from
exoribonuleases, and the remaining 40-nt were ribonucleotides. The chimeric oligo was immobilized on streptavidin-coated magnetic particles, which were used to isolate
proteins from whole cell lysates of S. aureus strain MN8. A
single 19.5 kDa protein was detectable by Coomassie
staining (data not shown), and was identified by Mass
Spectral analysis as the immunodominant surface antigen
B (IsaB).
We extensively analyzed the effect of deleting and overexpressing the isaB gene on ica expression but found that
it played no role in this capacity, suggesting that our
hypothesis that it was a post-transcriptional regulator of
ica expression was invalid (data not shown).
Localization of IsaB
In order to characterize the RNA binding activity of IsaB
we cloned the gene into the expression vector pYKB1 and
purified untagged protein using a chitin affinity column
(Figure 1). Polyclonal antiserum against the purified protein was used to localize IsaB within S. aureus (Figure 2).
Because the antiserum cross-reacted with other staphylococcal proteins, cellular fractions from an isogenic isaB
deletion mutant were included for the definitive identification of IsaB bands. IsaB was found in both the spent
medium and cell surface extracts of S. aureus, while it was
absent in both the cell membrane and cytoplasmic fractions.
Gel shift analysis revealed a lack of sequence specificity by
IsaB
To confirm the RNA-binding activity of purified IsaB,
Electrophoretic Mobility Shift assays (EMSAs) were performed. As shown in Figure 3A, IsaB binds RNA and produces an observable shift. As is commonly noted for

Table 1: Oligonucleotides used in this study are shown

Oligo name

Sequence

WTUTR-c
IsaBIntein
IsaBInteinREV
isaBDELFWD
isaBDELREV
isaBXhoFWD
isaBXhoREV
icaUTR6
BioticaPRO
IcaRcloneFWD
WTUTR(RNA)

5'-BIOTIN-TGCaauuacaaauauuuccguuuaauuauaacaacaaucuauuGCA-3'
5'-GGGCATATGAATAAAACCAGTAAAGTTTGTGTAGC-3'
5'-GGTTGCTCTTCCGCAACCTTTACTTGTTTTGTATGGTGTATGTCC-3'
5'-GGATCCCGGATTTAGGCAATTCTTTTAATGC-3'
5'-GGATCCCATTAGAACTAATGTGCTTTGATGG-3'
5'-GGGCATATGGTTTGTGTAGCAGCAACATTAGC-3'
5'-GGGCTCGAGCGAAGTAACAGTTGGACATACACC-3'
5'-GUUUAAUUAUAACAACAAUCUAUUGCA-3'
5'-BIOTIN-ATTGVGTTATCAATAATCTTA-3'
5'-GGTGGGATCCTTGAAGGATAAGATTA-3'
5'-Biot-tegugcaauuacaaauauuuccguuuaauuauaacaacaaucuauuGCA-3'

Deoxyribonucleotides are shown in capital letters and ribonucleotides are shown in lower case.
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Figure
SDS
PAGE
1 analysis of recombinant IsaB
SDS PAGE analysis of recombinant IsaB. IsaB-CBD
fusion peptide was produced in E. coli, purified over a chitin
column, and purified, untagged IsaB was cleaved off the column. Lane 1, molecular weight standards; Lane 2, whole cell
lysate; Lane 3, CBD tag stripped from chitin beads by boiling
in SDS PAGE loading buffer; Lane 4, purified IsaB after CBD
cleavage and column elution.
nucleic acid binding proteins, in the absence of carrier
DNA, much of the probe RNA remained trapped in the
well. Addition of sonicated salmon sperm DNA abolished
not only retention of the probe within the wells, but the
shift as well, indicating that IsaB readily interacted with
the carrier DNA. When the ratio of labeled RNA to unlabeled DNA was 2:1, the salmon sperm prevented the shift
observed with our labeled RNA oligo (Figure 3B), which
suggested a greater affinity of IsaB for the carrier DNA than
for the RNA. In order to test the sequence specificity of
IsaB, we used a panel of divergent DNA and RNA oligonucleotide probes and found that the nucleic acid-binding
activity of IsaB was not specific with regard to sequence
(results not shown).
Gel shift analysis revealed affinity for polymeric RNA and
DNA but not nucleotides
In order to further characterize the nucleic acid binding
activity of IsaB, EMSAs were performed using unlabeled
double-stranded DNA (sonicated salmon sperm), yeast
tRNA, and deoxyribonucleotides (dNTPs) as competitors
(Figure 4). As Figure 4 shows, both yeast tRNA and DNA
completely inhibited the IsaB-RNA shift. However, the
equivalent concentration of dNTPs was unable to inhibit
the shift, indicating that IsaB specifically bound to polymeric nucleic acids and not to free dNTPs.
BIAcore analysis of IsaB
The affinity of IsaB for nucleic acids was characterized by
BIAcore surface plasmon resonance. Using biotinylated
DNA, RNA, or double-stranded DNA bait oligonucle-
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Figure 2localization of IsaB by Western blot analysis
Cellular
Cellular localization of IsaB by Western blot analysis.
Sa113 and Sa113ΔisaB::erm cultures were fractionated into:
spent medium (lanes 1 and 2), cell wall associated (lanes 3
and 4), cell membrane (lanes 5 and 6) and cytoplasmic (lanes
7 and 8) fractions. IsaB bands were observed in both the
spent medium and cell wall associated fractions in wild-type
Sa113 (lanes 1 and 3, arrows) but not in Sa113ΔisaB::erm
(lanes 2 and 4 respectively). Proteins that reacted non-specifically with IsaB antiserum were observed in all lanes, but
were present in the isaB mutant as well as wildtype.

otides, we obtained affinities of IsaB to each of these ligands (Table 2). These data, in agreement with the EMSAs,
suggest that IsaB binds with the highest affinity to double
stranded DNA.
Deletion of isaB reduced the accumulation of extracellular
DNA on the bacterial cell surface
To determine whether native, cell surface-associated IsaB
was capable of binding extracellular DNA, wildtype
strains 10833 and SA113 and mutants 10833ΔisaB::erm
and SA113ΔisaB::erm were combined with fluorescently
labeled salmon sperm DNA. Relative fluorescence that
bound to the bacteria was measured with a fluorimeter. As
shown in Figure 5 more fluorescent DNA bound to the
wildtype strains. Specifically, there was a 2.2-fold increase
in fluorescence of 10833 versus 10833ΔisaB::erm and a
1.9-fold increase in SA113 versus SA113ΔisaB::erm.
Deletion of isaB did not affect biofilm formation
Isogenic isaB deletion mutants exhibited no apparent
growth defects under any conditions tested (data not
shown). Microtiter assays for biofilm formation in a variety of media did not reveal any contribution of IsaB to
biofilm formation and there was no significant difference
between 10833ΔisaB::erm and SA113ΔisaB::erm and their
respective wildtype parental strains in TSB, TSBG, BHI,
Page 3 of 10
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Figure 3
Electromobility
shift analysis of IsaB
Electromobility shift analysis of IsaB. A. Purified recombinant IsaB was analyzed by EMSA assay using a fluorescently
labeled RNA probe. IsaB shifted the RNA probe in a concentration dependent manner. A. Lane 1, RNA probe alone Lane 2,
RNA probe + 3.84 nmol of IsaB, Lane 3, RNA probe + 1.92 nmol of IsaB, Lane 4, RNA probe + 960 pmol of IsaB, Lane 5, RNA
probe + 480 pmol of IsaB, Lane 6, RNA probe + 240 pmol of IsaB. At the highest concentrations of IsaB, the RNA probe
appeared to aggregate within the wells, while at lower concentrations of IsaB (lanes 4–6) a fraction of the RNA shifted (arrow)
but some RNA still remained in the wells. B. Effect of salmon sperm DNA on shift; 480 pmol IsaB and 270 pmol labeled. RNA
were added to each reaction. Lane 1, RNA probe alone, Lane 2, IsaB, + RNA probe, Lane 3, IsaB + RNA probe and 1.35 nmol
unlabeled DNA, Lane 4, IsaB + RNA and 135 pmol unlabeled DNA, Lane 5, IsaB + RNA and 13.5 pmol unlabeled DNA, Lane 6,
IsaB + RNA and 1.35 pmol unlabeled DNA.
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Figure 4 Electromobility shift analysis
Competitive
Competitive Electromobility shift analysis. EMSAs
were performed with unlabeled competitors added to the
reactions. 480 pmol IsaB and 270 pmol labeled RNA were
included in each sample. Lane 1, labeled probe alone, Lane 2,
IsaB + labeled RNA, Lane 3, IsaB + labeled RNA and 270
pmol unlabeled DNA, Lane 4, IsaB + labeled RNA and 270
pmol dNTPs, Lane 5, IsaB + labeled RNA and 270 pmol yeast
tRNA.
BHIG, or LB (Figure 6). Surprisingly, although there was
no obvious visible difference, there was a statistically significant increase in the OD595 nm in the isaB deletion
mutants of both strains in LBG. This was consistent
between technical and biologic replicates. As extracellular
DNA has been shown to affect biofilm development in
flow cells [18], we also tested the wildtype and mutant
strains under flow conditions. However, there were no
observable differences in biofilm formation or maintenance between the isaB deletion mutants and their respective wildtype strains (data not shown).

Discussion
Immunodominant antigen B (IsaB) was first described by
Lorenz et al for its immunogenicity in patients recovering
Table 2: Dissociation and association constants for binding of
IsaB to double-stranded DNA, single-stranded DNA, and RNA as
determined by surface plasmon resonance

Ligand

Kd

Ka

Double-stranded DNA
Single-stranded DNA
RNA

8.10 × 10-9
1.08 × 10-8
1.65 × 10-8

1.23 × 108
9.28 × 107
6.07 × 107

Figure
IsaB
binds
5 eDNA on the cell surface
IsaB binds eDNA on the cell surface. S. aureus strains
10833, Sa113, and their isogenic isaB deletion mutants were
assayed for their ability to bind to a fluorescently labeled oligonucleotide. The y-axis represents the relative light units.
Wildtype fluorescence levels were significantly higher with a
probability value of p = 0.006 for 10833 versus
10833ΔisaB::ern and Sa113 versus Sa113ΔisaB::erm (Student's
unpaired T test).
from septicemia [5]. While IsaB has been referred to as a
virulence factor [7,9], the amino acid sequence does not
display significant homology to other proteins of known
function, and to date its function remains unknown. In
this study we serendipitously discovered the nucleic acidbinding activity of IsaB in a RNA Affinity Chromatography assay designed to identify factors that regulate ica
expression post-transcriptionally. However, further experiments indicated that while IsaB binds the transcript, it
does not affect ica expression, and does not play a significant role in the post-transcriptional regulation of ica. Furthermore, IsaB was present in the spent medium and
associated with the bacterial cell surface but was not
found in the cytoplasm where it could function as a posttranscriptional regulatory factor.
To further characterize the RNA-binding activity of IsaB
we used EMSAs and found that, while IsaB did bind RNA,
the interaction was not sequence-specific and it was also
capable of binding to single-stranded and doublestranded DNA. However, we did find that IsaB only binds
to polymeric nucleic acids and not to deoxyribonucleotides, suggesting that the nucleic acid binding activity is
not a side-effect of a nucleotide-binding site.
IsaB contains an amino-terminal signal peptide and is
predicted by PSORTb to be secreted [22]. We found that
indeed, IsaB is secreted into the spent medium, but a significant fraction was associated with the cell wall. According to analysis with PSORTb, IsaB lacks an LPXTG motif,
so it is not immediately clear how it is retained on the cell
surface.
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Figure 6 plate assay for biofilm formation
Microtiter
Microtiter plate assay for biofilm formation. Strains SA113 and 10833 and their isogenic isaB deletion mutants were
screened for their ability to form biofilms in different media; TSB, TSB+1% glucose and 3.5% NaCl, BHI, BHI+1% glucose, LB,
or LB+1% glucose. A. Safranin-stained biofilms and B. Average OD595 nm values of 8 wells from three separate experiments (24
values) of solubilized safranin-stained biofilms. Deletion of isaB did not reduce biofilm formation under any conditions tested
but there was a statistically significant increase in OD595 nm in the absence of isaB in LBG.
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In a recent study Rice et al found that extracellular DNA
(eDNA) can contribute to the structural stability of biofilms in S. aureus, and that DNase-induced degradation of
the eDNA leads to dissolution of the biofilm [18]. Furthermore, IsaB expression was found to be upregulated
within biofilms [8], which lead us to hypothesize that
binding of eDNA by IsaB could play a role in the establishment or maturation of biofilms, which are a critical component of disease establishment and progression of S.
aureus. We found, using fluorescently-labeled DNA, that
IsaB does play a role in accumulation of extracellular DNA
on the bacterial cell surface, however, under our experimental growth conditions, IsaB did not contribute to biofilm-forming capacity. Surprisingly, deletion of isaB
actually increased biofilm formation slightly, but significantly, in LB containing 1% glucose. This suggests that the
role of IsaB may differ depending upon the growth conditions. We are therefore currently exploring the possibility
that IsaB may play a more significant role in biofilm formation under more physiologic conditions, and whether
or not it contributes to virulence in an animal model of
bacteremia.
IsaB elicits an immune response during sepsis, suggesting
that it is expressed during infection [5]. Its expression is
also induced by neutrophils and following internalization
in human epithelial cells, again suggesting expression during infection and a role in virulence [4,7-9]. However, it is
not immediately clear how an extracellular DNA-binding
protein could play a role in virulence. eDNA present at the
site of an infection may come from a variety of sources
including lysed neutrophils or neutrophils actively releasing NETs (neutrophil extracellular traps) or from lysed
bacterial cells [23,24]. If IsaB does not play a role in biofilm formation, then binding of extracellular DNA to the
cell surface could be a mechanism of immune evasion by
mimickry or it could result in repulsive forces between the
DNA-coated bacteria and the DNA in NETs. We are currently investigating these potential functions of IsaB.

Conclusion
IsaB is a putative virulence factor and its expression is
induced as a result of a variety of conditions related to the
in vivo disease state. In the data presented here we show
that IsaB is an extracellular nucleic acid binding protein
with a greater affinity for dsDNA than for ssDNA or RNA.
Using isogenic deletion mutants we were unable to demonstrate a role for IsaB on biofilm formation. Further
studies are necessary to determine what role IsaB and its
nucleic acid-binding activity play in establishment and/or
progression of S. aureus infection.

Methods
Strains and growth conditions
MN8 is a clinical S. aureus isolate from a Toxic Shock Syndrome patient, which was isolated by Dr. Patrick Schliev-
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ert (University of Minnesota, MN). Strain 10833 is
positive for clumping factor (ATCC 25904), is positive for
capsular polysaccharide CP5, and is closely related to the
sequenced strain Newman. SA113 is closely related to
NCTC 8325 and is capsular polysaccharide negative.
RN4220 is a restriction deficient laboratory strain from
Dr. Richard Novick (Skirball Institute of Molecular Medicine, New York University, NY). The strains were grown at
37°C on tryptic soy agar plates and liquid cultures were
either in Luria Bertani broth (LB) or LB+1% glucose
(LBG).
RNA Affinity chromatography
Affinity Chromatography was performed essentially as
previously described [13]. S. aureus MN8 was grown overnight in 4 L TSB. The bacteria were collected by centrifugation and lysed using a French Pressure cell. A singlestranded chimeric oligonucleotide probe, WTUTR-c was
synthesized with a 5' biotin tag; deoxyribonucleotides
were included to protect the ends from exoribonucleases
(Table 1). 200 nmol of the oligo was immobilized on 10
mg of streptavidin-coated M-280 Dynabeads (Invitrogen,
Carlsbad, CA) according to the manufacturer's instructions. The beads were equilibrated with binding buffer-1
(BB-1: 10 mM HEPES, 60 mM KCl, 4 mM MgCl2, 0.1 mM
EDTA, 0.1 mg/ml BSA, and 0.25 mM DTT). 1.5 mL lysate
(approximately 20 mg of protein) was combined with 6
ml BB1, 0.5 mg sonicated salmon sperm DNA (SSS) and
0.1 mg yeast tRNA, and chilled on ice for 10 min. The
lysate mixture was added to the beads and incubated on
ice for 10 min. The beads were washed once with BB1+ 0.2
mg/ml SSS, and 10 μg/mL yeast tRNA and twice with BB1
without BSA, SSS, or tRNA. RNA-binding proteins were
eluted with 1 ml 10 mM HEPES + 0.25 M KCl. The eluate
was concentrated and desalted using Microcon YM-3.5
centrifugal concentrators (Millipore, Billerica, MA). The
concentrated sample was subjected to SDS PAGE using
NuPAGE 4–15% gradient gels and MOPS buffer (Invitrogen). The gels were stained with Coomassie blue and protein bands were excised and submitted to the Molecular
Biology Core Facility (Dana-Farber Cancer Institute, Boston, MA) for sequencing by MALDI-TOF mass spectral
analysis.
Expression of IsaB in E. coli
The isaB gene excluding the signal sequence was amplified
from 10833 total DNA by PCR using primers IsaBIntein
and IsaBInteinREV. The PCR product was digested with
NdeI and SapI and cloned into the pYKB1 vector (New
England Biolabs, Bedford, MA) using Ready-to-go ligase
(Amersham, Piscataway, NJ). The pYKB1 vector fuses a
carboxy terminal chitin-binding domain (CBD) onto the
protein. The ligation reaction was used to transform
TOP10 E. coli (Invitrogen) and successful transformants
were selected by resistance to 50 μg kanamycin/mL. The
plasmid was sequenced to confirm the lack of mutations
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within isaB and it was used to transform the BL21pLysS(DE3)-pRIL strain of E. coli (Stratagene, La Jolla,
CA). 1 L of LB containing 50 μg kanamycin/mL and 35 μg
chloramphenicol/mL was inoculated with 50 mL of overnight culture and incubated at 37°C for 3 hours. The culture was induced with 1 mmol IPTG and incubated 3
hours at 37°C. The bacteria were collected by centrifugation, and resuspended in 25 ml of CBD buffer (20 mM
Tris-CL pH 7.0 containing 0.5 M NaCl) with 0.1% Triton
X-100 and protease inhibitors (Roche, Indianapolis, IN).
The bacteria were lysed using a French pressure cell followed by 6 × 20 sec 9 Watt pulses with a probe-type sonicator. Intact cells and debris were removed by
centrifugation, and the supernatant was filtered through a
0.45 μm filter. 8 mL chitin resin (New England Biolabs)
was poured into a column, washed once with 10 mL H2O
and twice with CBD buffer. The lysate was applied to the
column, and the column was rinsed 3× with 15 ml of CBD
buffer, once with 15 mL CBD buffer containing 1% TritonX-100, 3× with 15 mL CBD buffer, and finally with 15
mL CBD buffer containing 50 mM dithiothreitol (DTT),
and the column was incubated 16 hours at 4°C. The column was eluted with 50 mL of CBD buffer and the eluate
was concentrated and desalted using 5,000 MW Amicon
Ultra concentrators.
Polyclonal antibodies against purified recombinant IsaB
were produced in rabbits (Invitrogen) following the company's standard immunization protocol. The polyclonal
antiserum was subsequently used for detection of IsaB by
western analysis.
Deletion of isaB
We replaced the isaB gene with an erythromycin resistance
cassette in S. aureus strain RN4220 using the pMAD vector
(kindly provided by Michel Débarbouillé and Maryvonne
Arnaud Pasteur Institute, Paris, France). The isaB gene and
surrounding sequence were amplified from total DNA
from strain 10833 using primers isaBDELFWD and isaBDELREV and the PCR product was cloned into the pCR4TOPO vector. To delete isaB, the plasmid was amplified
with primers isaBXhoFWD and isaBXhoREV. The PCR
product was treated with DpnI to digest the original methylated plasmid; it was then digested with XhoI and ligated
to an erythromycin resistance cassette excised from plasmid pSC57 with XhoI. The region surrounding the isaB
gene and the intervening erm cassette were excised with
BamHI and ligated to pMAD. This construct was electroporated into strain RN4220 as described by Lee [25].
Transformants were cultured overnight at 30°C in the
presence of 10 μg erythromycin/ml, diluted 1:1000 and
sub-cultured overnight at 42°C without antibiotics. The
cultures were diluted 1:10, plated on LB agar plates containing 10 μg erythromycin/ml and 200 μg X-gal/ml, and
grown for at 42°C. White colonies were picked and
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screened for the double-crossover event, initially by PCR,
and then by DNA sequencing, which was carried out by
the Microbiology Core Facility at Harvard Medical School
(Boston, MA). The mutation was transduced to strain
10833 using phage 80α [26] to produce strains
10833ΔisaB::erm and SA113ΔisaB::erm.
Cellular localization of IsaB
Sa113 and Sa113ΔisaB::erm were grown in 1 L TSB for 6–
10 hours. Cultures were centrifuged and both the cell pellet and spent medium were collected. Protein from 400
ml spent medium was precipitated by 70% saturation
(NH4)2SO4, while stirring at 4°C for 1 hour. Precipitated
proteins were collected by centrifugation, the resulting
pellet was resuspended in 1 ml of PBS with complete protease inhibitor cocktail tablets (Roche Diagnostics). The
samples were dialyzed against 3 L of 0.1× PBS overnight at
4°C before gel electrophoresis.

The cell pellet was washed with PBS and resuspended in
20 ml of Buffer A (40 mM Tris-Cl, 100 mM NaCl, 27%
Sucrose, 20 mM MgCl2, and protease inhibitor cocktail 1/
50 ml). 500 μg lysostaphin was added and the cells were
incubated for 4 hours at 37°C. The pellet (protoplasts)
and supernatant (peptidoglycan) were separated by centrifugation. The cell pellet was resuspended in 10 ml of
water, 1% triton X was added and mixture was rocked for
10 min at RT. Samples were centrifuged 10,000 × g for 20
min to remove intact cells and membranes were collected
by centrifugation at 100,000 × g for 1 hr. Following centrifugation the supernatant (cytoplasm) was collected and
the pellet (membrane) was resuspended in water. Equal
amounts of protein from the four cellular fractions were
analyzed by denaturing PAGE using NuPAGE® 4–12% BisTris gels (Invitrogen) according to manufacturer's instructions. The proteins were transferred onto a PVDF membrane which was then blocked 1 hr in PBS containing 5%
skim milk. The blot was probed with a 1:5,000 dilution of
IsaB-specific rabbit antisera in PBS containing 0.05%
tween (PBST) and 0.5% skim milk followed by a 1:10,000
fold dilution of goat anti-rabbit horseradish peroxidase
conjugated IgG in PBST. Proteins were detected using the
ECL Plus detection system (Amersham) and analyzed
with a CCD camera (Kodak).
Electrophoretic mobility shift analysis
Probes for EMSAs were fluorescently labeled with the
ULYSIS™ Alexa Fluor® 594 Nucleic Acid labeling kit (Invitrogen) according to manufacturer's instructions. Mobility
shift reaction mixtures containing 20 μL binding buffer
(BB1: 20 mM HEPES, 1 mM DTT, 20 mM KCl, 200 μg
BSA/ml, 10% glycerol), 480 pmol purified, recombinant
IsaB (optimal concentration determined from Figure 3A,
which had either 3.84 nmol, 1.92 nmol, 960 pmol, 480
pmol, or 240 pmol of purified, recombinant IsaB), and
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270 pmol RNA probe icaUTR6 were incubated for 10 minutes at room temperature. The reactions were loaded onto
a 2% acrylamide gel, bromophenol blue was added to one
lane as a marker, and the gel was electrophoresed at 100 V
for 30 min. Bands were visualized using a CCD camera.
Salmon sperm DNA (SSS) was serially diluted 10-fold and
added to designated reactions at final concentrations
ranging from 1.35 nmol-1.35 pmol. For inhibition analysis, 2.7 nmol of either salmon sperm DNA (Invitrogen),
nucleotides, or yeast tRNA (Sigma, St. Louis, MO) were
added in addition to the standard mobility shift reaction
mixtures.
Surface Plasmon Resonance
IsaB interactions with RNA, DNA, and dsDNA were analyzed using a BIAcore Model T100 (BIAcore International,
Piscataway, NJ) following manufacturer's instructions.
Biotinylated oligos, DNA and RNA, were immobilized on
a Streptavidin chip (SA sensor chip, BIAcore International) in 0.33× HBS-EP buffer, supplemented with 1× of
non-specific binding inhibitor (BIAcore International).
Double-stranded DNA was created by loading the SA
DNA coated chip with the complementary strand, icaRcloneFWD. The first flow chamber was left blank to allow
for normalization and subtraction of non-specific binding. Resonance units were determined using decreasing
concentrations of IsaB that were loaded onto the chip at a
flow rate of 30 μl/ml. The kD and kA were determined
with the BIA Evaluation Software.
S. aureus binding to fluorescently labeled oligonucleotide
Overnight cultures of S. aureus strains 10833 and
10833ΔisaB::erm were diluted 1:20 in fresh media
(TSB+1% glucose) and incubated at 37°C with shaking.
After 4 hours of incubation, approximately 108 bacteria
were collected by centrifugation and resuspended in binding buffer (20 mM HEPES, 1 mM DTT, 20 mM KCl, 200
μg BSA/ml). 40 ng ULYSIS™ Alexa Fluor® 488-labeled SSS
was added and the reactions were incubated for 15 minutes at room temperature. Control reactions lacked the
fluorescent oligonucleotide. Following incubation, the
cells were washed once in binding buffer, and resuspended in 200 μl of water. Fluorescent counts were determined using an Flx800 (BioTek, Winooski, VT).
Experiments were performed in triplicate and statistical
significance was determined using an unpaired T-test.
Biofilm assays
Biofilm assays were performed essentially as described by
Christensen [27]. Overnight cultures of S. aureus strains
10833, 10833ΔisaB::erm, Sa113, and Sa113ΔisaB::erm
were diluted 1:20 in fresh media (TSB, TSB+1% glucose
+3.5% NaCl, BHI, BHI+1% glucose, LB, or LB+1% glucose) in a microtiter plate. Cultures were incubated overnight at 37°C. The following day, the media was removed,
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plates were washed with 1× PBS, dried and stained with
safranin. Stained biofilms were resuspended in 200 μL
water using a probe sonicator and the optical density at
595 nm (OD595 nm) was determined using an ELISA plate
reader. Values from eight wells per experiment and three
separate experiments were averaged. Analysis of biofilm
formation over a 48 hr period in flow cells (Stovall,
Greensboro, NC) was conducted essentially as described
by Rice et al and biofilm thickness was judged visually
[18].
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